Surgimab (France)

Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study

Leonora S. F. Boogerd, Charlotte E.S. Hoogstins, Dennis P. Schaap et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 197 citations · Full text

Medicine, Oncology, Surgery +17

Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent

Charlotte E.S. Hoogstins, Leonora S. F. Boogerd, Babs G. Sibinga Mulder et al. · Annals of Surgical Oncology · 2018 · 153 citations · Full text

Medicine, Oncology, Radiology +17

SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery

Marian Gutowski, Bérénice Framery, Martin C. Boonstra et al. · Surgical Oncology · 2017 · 109 citations · Full text

Medicine, Molecular Biology, Oncology +17

Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer

Kim S. de Valk, Marion M. Deken, Dennis P. Schaap et al. · Annals of Surgical Oncology · 2020 · 73 citations · Full text

Medicine, Oncology, Surgery +17

Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer

Dennis P. Schaap, Kim S. de Valk, Marion M. Deken et al. · British journal of surgery · 2020 · 59 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +1